Patents by Inventor Wolfgang Schroeder

Wolfgang Schroeder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Spiro(5.5)undecane derivatives
    Patent number: 8288430
    Abstract: The invention relates to compounds that have an affinity to the ?-opioid receptor and the ORL 1-receptor, methods for their production, medications containing these compounds and the use of these compounds for the treatment of pain and other conditions.
    Type: Grant
    Filed: March 25, 2009
    Date of Patent: October 16, 2012
    Assignee: Grunenthal GmbH
    Inventors: Saskia Zemolka, Stefan Schunk, Klaus Linz, Wolfgang Schröder, Werner Englberger, Fritz Theil, Birgit Roloff
  • SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS
    Publication number: 20120258947
    Abstract: Substituted 6-amino-nicotinamides, pharmaceutical compositions containing these compounds and also use of these compounds in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: April 18, 2012
    Publication date: October 11, 2012
    Applicant: Grunenthal GmbH
    Inventors: Sven KÜHNERT, Gregor Bahrenberg, Achim Kless, Wolfgang Schröder, Simon Lucas
  • Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators
    Publication number: 20120252841
    Abstract: The invention relates to substituted 2-mercaptoquinoline-3-carboxamides, methods for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.
    Type: Application
    Filed: June 15, 2012
    Publication date: October 4, 2012
    Applicant: DRUNENTHAL GMBH
    Inventors: Sven KÜHNERT, Gregor BAHRENBERG, Achim KLESS, Wolfgang SCHRÖDER
  • Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
    Publication number: 20120220627
    Abstract: The invention relates to substituted 2-amino-quinoline-3-carboxamides, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: August 26, 2011
    Publication date: August 30, 2012
    Applicant: Grunenthal GmbH
    Inventors: Sven KÜHNERT, Gregor BAHRENBERG, Dagmar KAULARTZ, Achim KLESS, Wolfgang SCHRÖDER
  • Substituted N-(2-mercaptopyridin-3-yl)amides as KCNQ2/3 modulators
    Patent number: 8247573
    Abstract: The invention relates to substituted N-(2-mercaptopyridin-3-yl)amides, methods for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.
    Type: Grant
    Filed: March 10, 2010
    Date of Patent: August 21, 2012
    Assignee: Gruenenthal GmbH
    Inventors: Sven Kühnert, Beatrix Merla, Achim Kless, Gregor Bahrenberg, Wolfgang Schröder
  • SUBSTITUTED NICOTINAMIDES AS KCNQ2/3 MODULATORS
    Publication number: 20120184550
    Abstract: Substituted nicotinamides, processes for their preparation, medicaments comprising these compounds and methods of using these compounds to treat pain, epilepsy, urinary incontinence, anxiety, dependency, mania, bipolar disorders, migraine, cognitive diseases, and/or dystonia-associated dyskinesias.
    Type: Application
    Filed: March 30, 2012
    Publication date: July 19, 2012
    Applicant: GRUNENTHAL GMBH
    Inventors: SVEN Kühnert, Beatrix Merla, Gregor Bahrenberg, Wolfgang Schröder
  • Substituted 3-amino-2-mercaptoquinolines as KCNQ2/3 modulators
    Patent number: 8207342
    Abstract: The invention relates to substituted 3-amino-2-mercaptoquinolines, to processes for their preparation, to medicaments containing these compounds and to the use of these compounds in the preparation of medicaments.
    Type: Grant
    Filed: March 10, 2010
    Date of Patent: June 26, 2012
    Assignee: Gruenenthal GmbH
    Inventors: Sven Kühnert, Gregor Bahrenberg, Wolfgang Schröder
  • Substituted nicotinamides as KCNQ2/3 modulators
    Patent number: 8178684
    Abstract: The invention relates to substituted nicotinamides, to processes for their preparation, to medicaments comprising these compounds and to the use of these compounds in the preparation of medicaments.
    Type: Grant
    Filed: March 10, 2010
    Date of Patent: May 15, 2012
    Assignee: Gruenenthal GmbH
    Inventors: Sven Kühnert, Beatrix Merla, Gregor Bahrenberg, Wolfgang Schröder
  • SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS
    Publication number: 20120101079
    Abstract: Substituted 6-amino-nicotinamides, pharmaceutical compositions containing these compounds and also use of these compounds in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: October 19, 2011
    Publication date: April 26, 2012
    Applicant: Grunenthal GmbH
    Inventors: Sven Kühnert, Gregor Bahrenberg, Achim Kless, Wolfgang Schröder, Simon Lucas
  • Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators
    Publication number: 20120053206
    Abstract: The invention relates to substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: August 26, 2011
    Publication date: March 1, 2012
    Applicant: Grunenthal GmbH
    Inventors: Sven KÜHNERT, Gregor Bahrenberg, Achim Kless, Wolfgang Schröder
  • Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators
    Publication number: 20120053205
    Abstract: The invention relates to substituted 2-oxy-quinoline-3-carboxamides, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: August 26, 2011
    Publication date: March 1, 2012
    Applicant: Grünenthal GmbH
    Inventors: Sven Kühnert, Gregor Bahrenberg, Achim Kless, Wolfgang Schröder
  • Substituted quinoline-3-carboxamides as KCNQ2/3 modulators
    Publication number: 20120053204
    Abstract: The invention relates to substituted quinoline-3-carboxamides, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: August 26, 2011
    Publication date: March 1, 2012
    Applicant: Grunenthal GmbH
    Inventors: Sven Kühnert, Gregor Bahrenberg, Achim Kless, Wolfgang Schröder
  • Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators
    Publication number: 20120053203
    Abstract: The invention relates to substituted 1-oxo-dihydroisoquinoline-3-carboxamides, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: August 31, 2011
    Publication date: March 1, 2012
    Applicant: Grunenthal GmbH
    Inventors: Sven KÜHNERT, Gregor BAHRENBERG, Achim KLESS, Wolfgang SCHRÖDER
  • Axomadol or a Metabolite Thereof for Use in the Treatment of Irritable Bowel Syndrome
    Publication number: 20120022294
    Abstract: The invention relates to axomadol or a metabolite thereof for use in the treatment of irritable bowel syndrome.
    Type: Application
    Filed: June 29, 2011
    Publication date: January 26, 2012
    Applicant: Gruenenthal GmbH
    Inventors: Klaus Schiene, Petra Bloms-Funke, Thomas Christoph, Wolfgang Schroeder
  • Tapentadol for use in the treatment of irritable bowel syndrome
    Publication number: 20120004317
    Abstract: The invention relates to tapentadol for use in the treatment of Irritable Bowel Syndrome
    Type: Application
    Filed: June 29, 2011
    Publication date: January 5, 2012
    Applicant: Gruenenthal GmbH
    Inventors: Klaus SCHIENE, Petra Bloms-Funke, Thomas Christoph, Wolfgang Schroeder
  • Substituted nicotinamide compounds and uses thereof
    Patent number: 8084470
    Abstract: Substituted nicotinamide compounds corresponding to formula I a process for their preparation, pharmaceutical compositions containing these compounds, and the use thereof for the treatment or inhibition conditions such as pain, epilepsy, migraine, anxiety states, or urinary incontinence.
    Type: Grant
    Filed: September 17, 2008
    Date of Patent: December 27, 2011
    Assignee: Gruenenthal GmbH
    Inventors: Beatrix Merla, Sven Kuehnert, Robert Frank, Dagmar Kaulartz, Wolfgang Schroeder, Gregor Bahrenberg, Klaus Schiene
  • Substituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain
    Patent number: 8017772
    Abstract: Substituted tetrahydropyrrolopyrazine compounds corresponding to the formula I: processes for their preparation, pharmaceutical compositions comprising these compounds and the use of these compounds for the treatment and/or inhibition of pain and other disorders or disease states at least partly mediated by KCNQ2/3 K+ channels.
    Type: Grant
    Filed: September 11, 2009
    Date of Patent: September 13, 2011
    Assignee: Gruenenthal GmbH
    Inventors: Beatrix Merla, Thomas Christoph, Stefan Oberboersch, Klaus Schiene, Gregor Bahrenberg, Robert Frank, Sven Kuehnert, Wolfgang Schroeder
  • (Hetero)aryl cyclohexane derivatives
    Patent number: 7977370
    Abstract: The invention relates to compounds that have an affinity to the ?-opioid receptor and the ORL 1-receptor, methods for their production, medications containing these compounds and the use of these compounds for the treatment of pain and other conditions.
    Type: Grant
    Filed: March 25, 2009
    Date of Patent: July 12, 2011
    Assignee: Gruenenthal GmbH
    Inventors: Saskia Zemolka, Stefan Schunk, Bert Nolte, Klaus Linz, Wolfgang Schröder, Werner Englberger, Hans Schick, Helmut Sonnenschein, Birgitta Henkel, József Bálint
  • Substituted tetrahydropyrrolopyrazine compounds and the use thereof in pharmaceutical compositions
    Patent number: 7879858
    Abstract: Substituted tetrahydropyrrolopyrazine compounds corresponding to formula I a process for producing such compounds; and a method of using such compounds to treat or inhibit various disorders or disease states including pain, depression and anxiety.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: February 1, 2011
    Assignee: Gruenenthal GmbH
    Inventors: Beatrix Merla, Thomas Christoph, Stefan Oberboersch, Klaus Schiene, Gregor Bahrenberg, Robert Frank, Sven Kuehnert, Wolfgang Schroeder
  • MIXED ORL1/MU-AGONISTS FOR THE TREATMENT OF PAIN
    Publication number: 20110015220
    Abstract: The invention relates to the use of compounds which exhibit an affinity for the ?-opioid receptor of at least 100 nM (Ki value, human) and an affinity for the ORL-1 receptor, wherein the ratio between the affinities ORL1/?defined as 1/[Ki(ORL1)/Ki(?)] is from 0.1 to 30, for the treatment of pain.
    Type: Application
    Filed: September 21, 2010
    Publication date: January 20, 2011
    Applicant: GRUNENTHAL GMBH
    Inventors: KLAUS LINZ, BABETTE-YVONNE KÖGEL, WOLFGANG SCHRÖDER, THOMAS CHRISTOPH, JEAN DE VRY, ELMAR FRIDERICHS